default author photo

Anup Kasi

University of Kansas - Cancer Center

University of Kansas - Department of Internal Medicine

Kansas City, KS

United States

SCHOLARLY PAPERS

2

DOWNLOADS

183

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Cancer Therapy and Immunogenicity of COVID Vaccine – CANINE Study

Number of pages: 33 Posted: 05 Oct 2021
University of Kansas - Department of Internal Medicine, University of Kansas - Department of Pharmacy, University of Kansas - Department of Pharmacy, University of Kansas - Department of Internal Medicine, University of Kansas - Department of Electrical Engineering and Computer Science, University of Kansas - Department of Biostatistics & Data Science, University of Kansas - School of Medicine, University of Kansas - Department of Pharmacy, University of Kansas - Cancer Center, University of Kansas - Department of Internal Medicine, University of Kansas - Cancer CenterUniversity of Kansas - Department of Internal Medicine, University of Kansas - Department of Biostatistics & Data Science, University of Kansas - Clinical Research, Strategy and Operations, University of Kansas - Department of Internal Medicine, University of Kansas - Cancer Center, University of Kansas - Department of Internal Medicine, University of Kansas - Cancer Center, University of Kansas - Department of Internal Medicine, University of Kansas - Department of Electrical Engineering and Computer Science, University of Kansas - Clinical Research, Strategy and Operations, University of Kansas - Department of Pathology and Laboratory Medicine, University of Kansas - Department of Pathology and Laboratory Medicine, University of Kansas - Department of Pathology and Laboratory Medicine, University of Kansas - Department of Nursing, University of Kansas - Department of Internal Medicine and University of Kansas - Cancer Center
Downloads 148 (505,974)

Abstract:

Loading...

2.

Phase I/II Trial of Cabozantinib Plus Durvalumab in Advanced Gastroesophageal Cancer and Other Gastrointestinal Malignancies (CAMILLA): Phase Ib Safety and Efficacy Results

Number of pages: 387 Posted: 31 Aug 2022
University of Kansas - Cancer Center, H. Lee Moffitt Cancer Center and Research Institute - Division of Hematology and Medical Oncology, University of Kansas - Department of Biostatistics, University of Kansas - Cancer Center, University of Kansas - Cancer Center, University of Kansas - Cancer Center, University of Kansas - Cancer Center, University of Minnesota - Minneapolis - Department of Laboratory Medicine and Pathology, University of Kansas - Division of Medical Oncology, University of Kansas - Department of Radiology, University of Kansas - Cancer Center, University of Kansas - Cancer Center, University of Kansas - Cancer Center, University of Kansas - Cancer Center, University of Kansas - Cancer Center, University of Kansas - Department of Pathology and Laboratory Medicine, University of Kansas - Department of Biostatistics and University of Kansas - Cancer CenterUniversity of Kansas - Department of Internal Medicine
Downloads 35 (1,249,711)
Citation 1

Abstract:

Loading...